Marwa Zerhouni

发表

ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines

G. Pagès, G. Robert, P. Auberger, 2017, Oncotarget.

Modular synthesis of new C-aryl-nucleosides and their anti-CML activity.

G. Robert, P. Auberger, R. Benhida, 2018, Bioorganic & medicinal chemistry letters.

LAMP2 expression dictates azacytidine response and prognosis in MDS/AML

N. Mounier, J. Tamburini, G. Robert, 2019, Leukemia.

Running to Outcompete Metastasis.

Marwa Zerhouni, E. Piskounova, 2022, Cancer research.

In Vitro and in Vivo Evaluation of Fully Substituted (5-(3-Ethoxy-3-oxopropynyl)-4-(ethoxycarbonyl)-1,2,3-triazolyl-glycosides as Original Nucleoside Analogues to Circumvent Resistance in Myeloid Malignancies.

G. Robert, P. Auberger, R. Benhida, 2017, Journal of medicinal chemistry.

Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic Melanoma

P. Abbe, G. Robert, P. Auberger, 2021, Cancer Research.

Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia

A. Stamatoullas, P. Rohrlich, N. Mounier, 2019, International Journal of Molecular Sciences.

Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies

P. Abbe, R. Ballotti, F. Bost, 2021, Cell death & disease.

NADK Isoform 3 promotes oxidative stress resistance and melanoma metastasis

Leona Nease, Graciela Cascio, Marwa Zerhouni, 2023, bioRxiv.

Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis

P. Auberger, A. Jacquel, Marwa Zerhouni, 2024, bioRxiv.